SparX Group collects over $30m Series B

SparX Group, a Cayman Islands-based immunology company, has raised over $30 million in Series B funding.

SparX Group, a Cayman Islands-based immunology company, has raised over $30 million in Series B funding. HighLight Capital and Rotating Boulder Fund led the round.

Source: Press Release